Last reviewed · How we verify

R-Gene 10 — Competitive Intelligence Brief

R-Gene 10 (ARGININE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: arginine hydrochloride. Area: Metabolic.

marketed arginine hydrochloride Nitric oxide synthase, inducible Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

R-Gene 10 (ARGININE) — Pfizer.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
R-Gene 10 TARGET ARGININE Pfizer marketed arginine hydrochloride Nitric oxide synthase, inducible 1973-01-01
Cortef hydrocortisone Generic (originally Merck/Upjohn) marketed Corticosteroid [EPC] Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible 1952-01-01
Cortisol Cortisol University of Zurich marketed Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
Argimate ARGININE GLUTAMATE phase 3 arginine glutamate Nitric oxide synthase, inducible

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (arginine hydrochloride class)

  1. Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). R-Gene 10 — Competitive Intelligence Brief. https://druglandscape.com/ci/arginine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: